Every SEC Form 3/4/5 on record for this filer (CIK 1273885) — 9 issuers, 75 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| AVIR | Atea Pharmaceuticals, Inc. | Director | 2020-10-29 → 2026-06-23 | 14 | −$76,735 |
| KZR | Kezar Life Sciences, Inc. | Director | 2018-06-20 → 2026-05-11 | 15 | $3M |
| EPIX | ESSA Pharma Inc. | Director | 2020-10-01 → 2025-10-15 | 10 | $1M |
| RAIN | Rain Enhancement Technologies Holdco, Inc. | Director · lapsed | 2021-04-22 → 2024-01-26 | 9 | $3M |
| BCEL | Atreca, Inc. | Director · lapsed | 2019-06-19 → 2023-06-15 | 6 | — |
| FPRX | FIVE PRIME THERAPEUTICS, INC. | Director · lapsed | 2015-07-02 → 2021-04-19 | 12 | $216,594 |
| PTI | PROTEOSTASIS THERAPEUTICS, INC. | Director · lapsed | 2016-02-10 → 2020-07-01 | 11 | $2M |
| TOCA | Tocagen Inc | Director · lapsed | 2017-04-12 → 2019-10-04 | 6 | — |
| IMDZ | IMMUNE DESIGN CORP. | Director · lapsed | 2016-01-06 → 2019-04-04 | 8 | −$106,500 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| AVIR | 2025-01-16 | Buy | 10,000 | $3.36 | $33,600 | 476,897 |
| AVIR | 2025-01-16 | Buy | 10,000 | $3.36 | $33,600 | 476,897 |
| AVIR | 2025-01-15 | Buy | 15,000 | $3.19 | $47,850 | 466,897 |
| AVIR | 2025-01-15 | Buy | 15,000 | $3.19 | $47,850 | 466,897 |
| AVIR | 2024-12-10 | Sell | 359,606 | $2.85 | $1M | 451,897 |
2 of 9 issuers are covered and open a security page; the rest are on file here only.
